ID | Name | Number of studies | |
---|---|---|---|
CL_0000625 | CD8-positive, alpha-beta T cell | 55 | |
CL_0001050 | effector CD8-positive, alpha-beta T cell | 9 |
Gene | Number of supported studies | Average coverage | Other major groups (express this gene) | Other cell types (express this gene) | |
---|---|---|---|---|---|
GZMH | 9 | 51% ± 24% | 0 | 13 | |
GZMK | 8 | 45% ± 24% | 0 | 17 | |
PRF1 | 8 | 56% ± 24% | 0 | 21 | |
CD8B | 7 | 57% ± 17% | 0 | 12 | |
IFNG | 6 | 31% ± 10% | 0 | 11 | |
SH2D1A | 7 | 29% ± 7% | 0 | 22 | |
TIGIT | 6 | 30% ± 16% | 0 | 13 | |
KLRD1 | 6 | 47% ± 18% | 0 | 15 | |
GZMM | 7 | 50% ± 16% | 0 | 27 | |
SH2D2A | 6 | 32% ± 12% | 0 | 20 | |
FGFBP2 | 5 | 43% ± 17% | 0 | 11 | |
LAG3 | 5 | 40% ± 17% | 0 | 12 | |
THEMIS | 5 | 23% ± 6% | 0 | 17 | |
CD8A | 9 | 59% ± 22% | 1 | 15 | |
GZMA | 9 | 73% ± 24% | 1 | 26 | |
GZMB | 7 | 70% ± 15% | 1 | 17 | |
GNLY | 7 | 60% ± 19% | 1 | 20 | |
CD3G | 7 | 60% ± 21% | 1 | 29 | |
OASL | 5 | 23% ± 8% | 1 | 12 | |
IL2RB | 6 | 22% ± 5% | 1 | 22 | |
SAMD3 | 6 | 35% ± 11% | 1 | 22 | |
CD3D | 8 | 72% ± 25% | 2 | 34 | |
LIME1 | 6 | 31% ± 4% | 2 | 22 | |
CD96 | 7 | 34% ± 9% | 2 | 33 | |
BATF | 6 | 34% ± 18% | 2 | 23 | |
LCK | 7 | 57% ± 26% | 2 | 34 | |
CD247 | 7 | 41% ± 16% | 2 | 34 | |
CD7 | 8 | 55% ± 16% | 3 | 37 | |
APOBEC3G | 7 | 43% ± 18% | 3 | 28 | |
NKG7 | 9 | 82% ± 26% | 4 | 40 |
GO_0002357 | Biological process | defense response to tumor cell |
GO_0090312 | Biological process | positive regulation of protein deacetylation |
GO_0060559 | Biological process | positive regulation of calcidiol 1-monooxygenase activity |
GO_0033141 | Biological process | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO_0060333 | Biological process | type II interferon-mediated signaling pathway |
GO_0071169 | Biological process | establishment of protein localization to chromatin |
GO_1903543 | Biological process | positive regulation of exosomal secretion |
GO_1904783 | Biological process | positive regulation of NMDA glutamate receptor activity |
GO_0038196 | Biological process | type III interferon-mediated signaling pathway |
GO_1901857 | Biological process | positive regulation of cellular respiration |
GO_0035710 | Biological process | CD4-positive, alpha-beta T cell activation |
GO_0034393 | Biological process | positive regulation of smooth muscle cell apoptotic process |
GO_0045910 | Biological process | negative regulation of DNA recombination |
GO_0032747 | Biological process | positive regulation of interleukin-23 production |
Cell type name | effector CD8-positive, alpha-beta T cell |
Synonyms | effector CD8-positive alpha-beta T lymphocyte effector CD8-positive alpha-beta T-cell effector CD8-positive alpha-beta T-lymphocyte |
Description | A CD8-positive, alpha-beta T cell with the phenotype CCR7-negative, CD45RA-positive. |
Parent | CL_0000625 |